1. Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK/mTOR/autophagy pathway
   Wen-Dong Li et al, 2017 CrossRef
2. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
   Javier Ampuero, 2015, WJH CrossRef
3. Modulatory effects of metformin on mutagenicity and epithelial tumor incidence in doxorubicin-treated Drosophila melanogaster
   Victor Constante Oliveira et al, 2017, Food and Chemical Toxicology CrossRef
4. Metformin treatment alleviates polycystic ovary syndrome by decreasing the expression of MMP‐2 and MMP‐9 via H19/miR‐29b‐3p and AKT/mTOR/autophagy signaling pathways
   Zhilan Chen et al, 2019, J Cell Physiol CrossRef
5. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro
   Xu Chen et al, 2015, Tumor Biol. CrossRef
6. Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study
   Yaser Alkhatib et al, 2017, Leukemia & Lymphoma CrossRef
7. Combination of metformin and VSL#3 additively suppresses western-style diet induced colon cancer in mice
   Eun-Ju Chung et al, 2017, European Journal of Pharmacology CrossRef
8. Metformin‑induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)‑like inhibitory protein through a caspase‑dependent pathway in human renal cell carcinoma A498 cells
   Ji‑Hoon Jang et al, 2018, Oncol Lett CrossRef
9. Mechanism and application of metformin in kidney diseases: An update.
   Anni Song et al, 2021, Biomed Pharmacother CrossRef
10. Autophagy Modulators in Cancer: Focus on Cancer Treatment.
    Hye Jin Nam, 2021, Life (Basel) CrossRef
11. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets
    Sze Kiat Tan et al, 2022, Nat Rev Urol CrossRef
12. Metformin and colorectal cancer
    GAST覰 AMABLE et al, 2022 CrossRef